Pay in 4 interest-free payments of $7.21 Learn more
Ships within 48 hours · Estimated delivery Sep 4 - Sep 9
Chief Financial Officer Yemi Okupe told investors the decline in gross margin was due to scaling its GLP-1 offerings and strategic pricing for those products
Tranexamic acid and cysteamine are newer options that match hydroquinone's results with fewer side effects
Anti-Aging Skincare Products GHK-Cu is a game-changer for Anti-Aging skincare formulations, including serums, face creams, eye creams, and masks
Worth every moment
In September, we invested nearly $2 billion to increase our manufacturing footprint in Ireland. The Irish investment which includes GLP-1s but will also support other products in Lillys portfolio, including the recently approved Alzheimer's disease treatment Kisunla (donanemab) followed investments of $5.3 billion at a site in Indiana, $2 billion in North Carolina, and $2.5 billion in Germany
US$ 29.69
US$ 20.29
US$ 28.25
US$ 20.04
US$ 22.25
US$ 29.96
